IL1R1 and inflammation: Therefore, we examined in first proof-of-principle studies whether pharmacological inhibition of the IL-1R/TLR-signaling associated IRAK4 kinase alleviates pulmonary inflammation and affects the recruitment of neutrophils and MoAM upon acute and sub-chronic smoke exposure (Figure 8A).